Anbio Biotechnology Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	730	1,320	-	-	-	-
Market Cap Growth	97.86%	-	-	-	-	-
Enterprise Value	718.45	1,308	0	0	0	0
Last Close Price	16.64	30.07	-	-	-	-
PE Ratio	113.49	204.56	-	-	-	-
PS Ratio	84.46	152.64	-	-	-	-
PB Ratio	24.22	43.77	-	-	-	-
P/TBV Ratio	24.10	43.55	-	-	-	-
EV/Sales Ratio	83.09	151.26	-	-	-	-
EV/EBITDA Ratio	-	226.76	-	-	-	-
EV/EBIT Ratio	124.56	226.76	-	-	-	-
Net Debt / Equity Ratio	-0.39	-0.39	-0.68	-0.65	-0.69	-1.65
Net Debt / EBITDA Ratio	-2.06	-2.06	-5.89	-4.91	-	-1.70
Net Debt / FCF Ratio	1.77	1.77	-5.65	-10.78	-	-1.00
Asset Turnover	0.35	0.35	0.47	0.45	0	0.90
Inventory Turnover	-	-	-	18.94	0	-
Quick Ratio	177.12	177.12	7.41	11.65	6.14	2.06
Current Ratio	344.31	344.31	10.71	15.86	9.88	2.07
Return on Equity (ROE)	27.05%	27.05%	14.83%	16.47%	0.00%	100.00%
Return on Assets (ROA)	23.46%	23.46%	11.49%	13.17%	0.00%	49.96%
Return on Invested Capital (ROIC)	48.31%	48.31%	36.84%	42.73%	0.00%	501.20%
Return on Capital Employed (ROCE)	24.36%	24.36%	12.47%	14.33%	0.00%	96.85%
Earnings Yield	0.88%	0.49%	-	-	-	-
Buyback Yield / Dilution	-3.26%	-3.26%	-97.30%	-21435200.00%	0.00%	-
Total Shareholder Return	-3.26%	-3.26%	-97.30%	-21435200.00%	0.00%	-

SEC Filings: 10-K · 10-Q